Optiscan CEO Dr. Camile Farah has been featured in a recent article published by Manufacturers’ Monthly exploring the growing role of sovereign manufacturing in the future of digital pathology.

In the article, Camile discusses how pathology remains one of the most analogue areas of modern healthcare, still heavily reliant on manual workflows, glass slides and delayed reporting processes despite advances across other medical technologies.

He explains how the shift toward real-time digital pathology is not simply about digitising slides, but about fundamentally redesigning workflows through integrated imaging, software, connectivity and automation.

The article highlights how technologies such as optical biopsy and real-time cellular imaging are enabling clinicians to generate immediate insight at the point of care, without the need for freezing, sectioning or traditional slide preparation.

Camile also explores the increasing importance of sovereign manufacturing in healthcare, noting that advanced digital pathology systems rely on highly integrated hardware, software, robotics, cloud connectivity and AI-enabled analytics.

The piece positions advanced manufacturing not as a downstream activity, but as a critical clinical enabler that directly impacts workflow integration, system reliability, scalability and future innovation across healthcare environments.

Read the full article here.